Prophylactic effect of low-dose trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia in adult recipients of kidney transplantation: a real-world data study
Open Access
- 12 October 2022
- journal article
- research article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 125, 209-215
Abstract
No abstract availableKeywords
Funding Information
- Renji Hospital (2021ZYA022)
- Shanghai Shenkang Hospital Development Center
This publication has 23 references indexed in Scilit:
- Evaluation of a new commercial real-time PCR assay for diagnosis of Pneumocystis jirovecii pneumonia and identification of dihydropteroate synthase (DHPS) mutationsDiagnostic Microbiology and Infectious Disease, 2017
- The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular PathologyAmerican Journal of Transplantation, 2017
- Risk Evaluation and Outcome of Pneumocystis jirovecii Pneumonia in Kidney Transplant PatientsTransplantation Proceedings, 2016
- High Pneumocystis jirovecii colonization rate among haemodialysis patientsInfectious Diseases, 2016
- ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patientsJournal of Antimicrobial Chemotherapy, 2016
- Pneumocystis jirovecii colonization among renal transplant recipientsNephrology, 2013
- KDIGO clinical practice guideline for the care of kidney transplant recipients: a summaryKidney International, 2010
- Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled TrialsMayo Clinic Proceedings, 2007
- Prevention of Infection Due toPneumocystis cariniiAntimicrobial Agents and Chemotherapy, 1998
- Pharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patientsAntimicrobial Agents and Chemotherapy, 1995